(-)-epigallocatechin 3-gallate decreases expression ISO RGD:1550011 6480464 epigallocatechin gallate results in decreased expression of GLI1 mRNA, epigallocatechin gallate results in decreased expression of GLI1 protein CTD PMID:20395211 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1550011 6480464 epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in increased expression of GLI1 mRNA], epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in increased expression of GLI1 protein] CTD PMID:27058323 17alpha-ethynylestradiol affects expression ISO RGD:1550011 6480464 Ethinyl Estradiol affects the expression of GLI1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of GLI1 mRNA CTD PMID:17109907 17alpha-ethynylestradiol multiple interactions ISO RGD:1550011 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GLI1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO RGD:1550011 6480464 Ethinyl Estradiol results in decreased expression of GLI1 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1344225 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of GLI1 mRNA, Estradiol inhibits the reaction [SHH protein results in increased expression of GLI1 mRNA] CTD PMID:20434536 , PMID:30165855 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of GLI1 mRNA CTD PMID:15328011 more ... 17beta-estradiol multiple interactions EXP 6480464 Estradiol promotes the reaction [Plant Preparations results in decreased expression of GLI1 mRNA] CTD PMID:26945725 17beta-estradiol decreases expression ISO RGD:1550011 6480464 Estradiol results in decreased expression of GLI1 mRNA CTD PMID:15289156 17beta-estradiol multiple interactions ISO RGD:1550011 6480464 [Estradiol co-treated with Progesterone] results in increased expression of GLI1 mRNA, Estradiol inhibits the reaction [SHH protein results in increased expression of GLI1 mRNA] CTD PMID:20434536 , PMID:22958837 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1550011 6480464 Dihydrotestosterone results in increased expression of GLI1 mRNA CTD PMID:29367455 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1550011 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GLI1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GLI1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550011 6480464 Tetrachlorodibenzodioxin affects the expression of GLI1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1550011 6480464 Tetrachlorodibenzodioxin results in decreased expression of GLI1 mRNA CTD PMID:17942748 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one decreases expression ISO RGD:1550011 6480464 Itraconazole analog results in decreased expression of GLI1 mRNA, Itraconazole results in decreased expression of GLI1 mRNA CTD PMID:21936514 , PMID:33905526 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one decreases expression EXP 6480464 Itraconazole results in decreased expression of GLI1 mRNA CTD PMID:33905526 3',5'-cyclic AMP multiple interactions ISO RGD:1344225 6480464 [BDNF protein co-treated with GDNF protein co-treated with Cyclic AMP co-treated with TGFB3 protein co-treated with Ascorbic Acid] results in decreased expression of GLI1 mRNA CTD PMID:33713149 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1550011 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of GLI1 mRNA CTD PMID:26251327 4,4'-sulfonyldiphenol decreases expression ISO RGD:1344225 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of GLI1 mRNA CTD PMID:27685785 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1550011 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of GLI1 exon CTD PMID:33297965 4,4'-sulfonyldiphenol increases expression ISO RGD:1550011 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of GLI1 mRNA CTD PMID:30951980 5-aza-2'-deoxycytidine increases expression ISO RGD:1550011 6480464 Decitabine results in increased expression of GLI1 mRNA CTD PMID:27915011 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1344225 6480464 [[Decitabine affects the methylation of HHIP promoter] which affects the expression of HHIP protein] which affects the expression of GLI1 mRNA CTD PMID:18559595 5-fluorouracil decreases expression ISO RGD:1344225 6480464 Fluorouracil results in decreased expression of GLI1 mRNA CTD PMID:18776995 5-fluorouracil multiple interactions ISO RGD:1344225 6480464 GLI1 protein inhibits the reaction [Fluorouracil affects the localization of PTCH1 protein] CTD PMID:18776995 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of GLI1 mRNA CTD PMID:24780913 , PMID:25825206 Ac-Ser-Asp-Lys-Pro-OH multiple interactions EXP 6480464 [goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in increased expression of GLI1 protein], goralatide inhibits the reaction [Silicon Dioxide results in increased expression of GLI1 protein] CTD PMID:31181250 Ac-Ser-Asp-Lys-Pro-OH multiple interactions ISO RGD:1344225 6480464 [goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in increased expression of GLI1 protein], goralatide inhibits the reaction [AGT protein results in increased expression of GLI1 protein] CTD PMID:31181250 acrylamide increases expression ISO RGD:1344225 6480464 Acrylamide results in increased expression of GLI1 mRNA CTD PMID:32763439 aflatoxin B1 decreases expression ISO RGD:1344225 6480464 Aflatoxin B1 results in decreased expression of GLI1 mRNA CTD PMID:22100608 aflatoxin B1 increases expression ISO RGD:1344225 6480464 Aflatoxin B1 results in increased expression of GLI1 mRNA CTD PMID:28965971 aflatoxin B1 increases methylation ISO RGD:1344225 6480464 Aflatoxin B1 results in increased methylation of GLI1 gene CTD PMID:27153756 aldehydo-D-glucose multiple interactions ISO RGD:1550011 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA more ... CTD PMID:27481074 aldehydo-D-glucose increases expression ISO RGD:1344225 6480464 Glucose results in increased expression of GLI1 protein CTD PMID:33992720 all-trans-retinoic acid multiple interactions ISO RGD:1344225 6480464 [Tretinoin co-treated with SHH protein co-treated with FGF8 protein] results in increased expression of GLI1 mRNA CTD PMID:17085092 all-trans-retinoic acid affects expression EXP 6480464 Tretinoin affects the expression of GLI1 mRNA CTD PMID:22262565 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of GLI1 mRNA CTD PMID:20488242 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of GLI1 mRNA CTD PMID:16483693 apigenin decreases expression ISO RGD:1550011 6480464 Apigenin results in decreased expression of GLI1 mRNA, Apigenin results in decreased expression of GLI1 protein CTD PMID:20395211 Aroclor 1254 decreases expression ISO RGD:1550011 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of GLI1 mRNA, Chlorodiphenyl (54% Chlorine) results in decreased expression of GLI1 protein CTD PMID:30578594 arsane affects expression ISO RGD:1344225 6480464 Arsenic affects the expression of GLI1 mRNA CTD PMID:28615018 arsenic atom affects expression ISO RGD:1344225 6480464 Arsenic affects the expression of GLI1 mRNA CTD PMID:28615018 arsenite(3-) increases expression ISO RGD:1550011 6480464 arsenite results in increased expression of GLI1 mRNA CTD PMID:33053406 arsenous acid decreases expression ISO RGD:1344225 6480464 Arsenic Trioxide results in decreased expression of GLI1 mRNA, Arsenic Trioxide results in decreased expression of GLI1 protein CTD PMID:23861973 more ... arsenous acid multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Curcumin] inhibits the reaction [Cisplatin results in increased expression of GLI1 protein], Arsenic Trioxide inhibits the reaction [Cisplatin results in increased expression of GLI1 protein] CTD PMID:31612257 arsenous acid increases response to substance ISO RGD:1344225 6480464 GLI1 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:21183792 aspartame multiple interactions ISO RGD:1344225 6480464 TAS1R1 protein affects the reaction [Aspartame affects the localization of GLI1 protein] CTD PMID:33992720 aspartame affects localization ISO RGD:1344225 6480464 Aspartame affects the localization of GLI1 protein CTD PMID:33992720 baicalein decreases expression ISO RGD:1550011 6480464 baicalein results in decreased expression of GLI1 mRNA, baicalein results in decreased expression of GLI1 protein CTD PMID:20395211 benzo[a]pyrene affects methylation ISO RGD:1344225 6480464 Benzo(a)pyrene affects the methylation of GLI1 5' UTR CTD PMID:27901495 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1550011 6480464 Diethylhexyl Phthalate results in decreased expression of GLI1 mRNA CTD PMID:28123099 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GLI mRNA CTD PMID:18180321 bisphenol A increases expression ISO RGD:1344225 6480464 bisphenol A results in increased expression of GLI1 protein CTD PMID:29307715 bisphenol A increases expression ISO RGD:1550011 6480464 bisphenol A results in increased expression of GLI1 mRNA CTD PMID:30951980 bisphenol A affects methylation ISO RGD:1550011 6480464 bisphenol A affects the methylation of GLI1 promoter CTD PMID:27334623 bisphenol A decreases expression ISO RGD:1344225 6480464 bisphenol A results in decreased expression of GLI1 mRNA CTD PMID:27685785 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GLI1 mRNA CTD PMID:25181051 , PMID:33296240 bisphenol F increases expression ISO RGD:1550011 6480464 bisphenol F results in increased expression of GLI1 mRNA CTD PMID:30951980 cadmium atom multiple interactions ISO RGD:1344225 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GLI1 mRNA more ... CTD PMID:34373904 cadmium dichloride multiple interactions ISO RGD:1344225 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GLI1 mRNA more ... CTD PMID:12634122 , PMID:34373904 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of GLI1 mRNA CTD PMID:30506660 cadmium dichloride increases expression ISO RGD:1550011 6480464 Cadmium Chloride results in increased expression of GLI1 mRNA CTD PMID:19818801 cannabidiol affects methylation EXP 6480464 Cannabidiol affects the methylation of GLI1 gene CTD PMID:30521419 captopril multiple interactions ISO RGD:1344225 6480464 [goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in increased expression of GLI1 protein] CTD PMID:31181250 captopril multiple interactions EXP 6480464 [goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in increased expression of GLI1 protein], Captopril inhibits the reaction [Silicon Dioxide results in increased expression of GLI1 protein] CTD PMID:31181250 chromium(6+) multiple interactions ISO RGD:1550011 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of GLI1 mRNA, SHH protein affects the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of GLI1 mRNA] CTD PMID:31756458 cisplatin multiple interactions ISO RGD:1344225 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of GLI1 mRNA CTD PMID:27392435 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of GLI1 protein CTD PMID:31612257 cisplatin multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Curcumin] inhibits the reaction [Cisplatin results in increased expression of GLI1 protein] more ... CTD PMID:31612257 cisplatin decreases expression ISO RGD:1344225 6480464 Cisplatin results in decreased expression of GLI1 mRNA CTD PMID:27392435 clothianidin decreases expression ISO RGD:1344225 6480464 clothianidin results in decreased expression of GLI1 mRNA CTD PMID:31626844 colforsin daropate hydrochloride decreases expression ISO RGD:1344225 6480464 Colforsin results in decreased expression of GLI1 mRNA, Colforsin results in decreased expression of GLI1 protein CTD PMID:30983542 copper atom multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in increased expression of GLI1 mRNA CTD PMID:26033743 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of GLI1 mRNA, Copper results in increased expression of GLI1 mRNA CTD PMID:26033743 , PMID:30556269 copper(0) multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in increased expression of GLI1 mRNA CTD PMID:26033743 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of GLI1 mRNA, Copper results in increased expression of GLI1 mRNA CTD PMID:26033743 , PMID:30556269 copper(II) sulfate affects expression ISO RGD:1344225 6480464 Copper Sulfate affects the expression of GLI1 mRNA CTD PMID:19549813 Cuprizon affects expression EXP 6480464 Cuprizone affects the expression of GLI1 mRNA CTD PMID:26577399 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of GLI1 mRNA CTD PMID:27523638 curcumin decreases expression ISO RGD:1550011 6480464 Curcumin results in decreased expression of GLI1 mRNA, Curcumin results in decreased expression of GLI1 protein CTD PMID:20395211 curcumin multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Curcumin] inhibits the reaction [Cisplatin results in increased expression of GLI1 protein], Curcumin inhibits the reaction [Cisplatin results in increased expression of GLI1 protein] CTD PMID:31612257 Cyclopamine multiple interactions ISO RGD:1344225 6480464 cyclopamine inhibits the reaction [SHH protein results in increased expression of GLI1 mRNA] CTD PMID:20434536 , PMID:31642701 Cyclopamine affects expression ISO RGD:1344225 6480464 cyclopamine affects the expression of GLI1 protein CTD PMID:20032413 Cyclopamine decreases expression EXP 6480464 cyclopamine results in decreased expression of GLI1 mRNA CTD PMID:21703336 Cyclopamine decreases expression ISO RGD:1550011 6480464 cyclopamine results in decreased expression of GLI1 mRNA, cyclopamine results in decreased expression of GLI1 protein CTD PMID:20179202 , PMID:20395211 Cyclopamine multiple interactions EXP 6480464 cyclopamine inhibits the reaction [Resveratrol results in increased expression of GLI1 protein] more ... CTD PMID:21110116 more ... Cyclopamine multiple interactions ISO RGD:1550011 6480464 cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA] more ... CTD PMID:20395211 more ... cyclosporin A decreases methylation ISO RGD:1344225 6480464 Cyclosporine results in decreased methylation of GLI1 promoter CTD PMID:27989131 D-glucose multiple interactions ISO RGD:1550011 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA more ... CTD PMID:27481074 D-glucose increases expression ISO RGD:1344225 6480464 Glucose results in increased expression of GLI1 protein CTD PMID:33992720 DDE multiple interactions ISO RGD:1344225 6480464 GLI1 affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of CCND1 protein], GLI1 affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of MYC protein] CTD PMID:25386960 DDE increases expression ISO RGD:1344225 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of GLI1 protein CTD PMID:25386960 diarsenic trioxide decreases expression ISO RGD:1344225 6480464 Arsenic Trioxide results in decreased expression of GLI1 mRNA, Arsenic Trioxide results in decreased expression of GLI1 protein CTD PMID:23861973 more ... diarsenic trioxide multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Curcumin] inhibits the reaction [Cisplatin results in increased expression of GLI1 protein], Arsenic Trioxide inhibits the reaction [Cisplatin results in increased expression of GLI1 protein] CTD PMID:31612257 diarsenic trioxide increases response to substance ISO RGD:1344225 6480464 GLI1 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:21183792 dibenzo[a,l]pyrene decreases expression ISO RGD:1550011 6480464 dibenzo(a, l)pyrene results in decreased expression of GLI1 mRNA CTD PMID:25908611 dibutyl phthalate decreases expression ISO RGD:1550011 6480464 Dibutyl Phthalate results in decreased expression of GLI1 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of GLI1 mRNA, Dibutyl Phthalate results in decreased expression of GLI1 protein CTD PMID:21266533 more ... dichromium trioxide multiple interactions ISO RGD:1344225 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of GLI1 mRNA CTD PMID:12634122 diethylstilbestrol decreases expression ISO RGD:1550011 6480464 Diethylstilbestrol results in decreased expression of GLI1 mRNA CTD PMID:15289156 dimethylarsinic acid multiple interactions ISO RGD:1550011 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GLI1 mRNA CTD PMID:34876320 dioxygen multiple interactions ISO RGD:1550011 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA more ... CTD PMID:27481074 embelin decreases expression ISO RGD:1344225 6480464 embelin results in decreased expression of GLI1 protein CTD PMID:24694877 embelin decreases expression ISO RGD:1550011 6480464 embelin results in decreased expression of GLI1 protein CTD PMID:24694877 ethanol decreases expression ISO RGD:1550011 6480464 Ethanol results in decreased expression of GLI1 mRNA CTD PMID:34492310 fulvestrant increases expression EXP 6480464 fulvestrant results in increased expression of GLI1 mRNA CTD PMID:20232216 genistein increases expression ISO RGD:1550011 6480464 Genistein results in increased expression of GLI1 mRNA CTD PMID:21810550 genistein multiple interactions ISO RGD:1550011 6480464 Genistein inhibits the reaction [SHH protein results in increased expression of GLI1 mRNA] CTD PMID:20395211 genistein decreases expression ISO RGD:1550011 6480464 Genistein results in decreased expression of GLI1 mRNA, Genistein results in decreased expression of GLI1 protein CTD PMID:15289156 , PMID:20395211 glucose multiple interactions ISO RGD:1550011 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA more ... CTD PMID:27481074 glucose increases expression ISO RGD:1344225 6480464 Glucose results in increased expression of GLI1 protein CTD PMID:33992720 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of GLI1 mRNA, Hydrogen Peroxide results in increased expression of GLI1 protein CTD PMID:31326407 hydrogen peroxide multiple interactions EXP 6480464 hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of GLI1 mRNA], hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of GLI1 protein] CTD PMID:31326407 ipriflavone multiple interactions ISO RGD:1550011 6480464 ipriflavone inhibits the reaction [SHH protein results in increased expression of GLI1 mRNA] CTD PMID:20434536 ipriflavone multiple interactions ISO RGD:1344225 6480464 ipriflavone inhibits the reaction [SHH protein results in increased expression of GLI1 mRNA] CTD PMID:20434536 itraconazole decreases expression ISO RGD:1550011 6480464 Itraconazole analog results in decreased expression of GLI1 mRNA, Itraconazole results in decreased expression of GLI1 mRNA CTD PMID:21936514 , PMID:33905526 itraconazole decreases expression EXP 6480464 Itraconazole results in decreased expression of GLI1 mRNA CTD PMID:33905526 L-ascorbic acid multiple interactions ISO RGD:1344225 6480464 [BDNF protein co-treated with GDNF protein co-treated with Cyclic AMP co-treated with TGFB3 protein co-treated with Ascorbic Acid] results in decreased expression of GLI1 mRNA CTD PMID:33713149 lead diacetate multiple interactions ISO RGD:1344225 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of GLI1 mRNA CTD PMID:12634122 lipopolysaccharide increases expression ISO RGD:1344225 6480464 Lipopolysaccharides results in increased expression of GLI1 protein CTD PMID:25069516 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of GLI1 mRNA CTD PMID:21110116 lipopolysaccharide multiple interactions EXP 6480464 cyclopamine inhibits the reaction [SHH protein inhibits the reaction [Lipopolysaccharides results in decreased expression of and results in decreased localization of GLI1 protein]] more ... CTD PMID:21110116 lipopolysaccharide multiple interactions ISO RGD:1344225 6480464 resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of GLI1 protein] CTD PMID:25069516 LY294002 decreases expression ISO RGD:1344225 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of GLI1 protein CTD PMID:25945059 melittin decreases expression ISO RGD:1344225 6480464 Melitten results in decreased expression of GLI1 protein CTD PMID:26189965 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of GLI1 mRNA CTD PMID:19564919 methylarsonic acid multiple interactions ISO RGD:1550011 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GLI1 mRNA CTD PMID:34876320 N-ethyl-N-nitrosourea increases mutagenesis ISO RGD:1550011 6480464 Ethylnitrosourea results in increased mutagenesis of GLI1 mRNA CTD PMID:27776689 N-methyl-N'-nitro-N-nitrosoguanidine increases expression EXP 150520178 MNNG increases expression of Gli1 mRNA in rat stomach RGD N-nitrosodiethylamine increases expression ISO RGD:1550011 6480464 Diethylnitrosamine results in increased expression of GLI1 mRNA, Diethylnitrosamine results in increased expression of GLI1 protein CTD PMID:27058323 N-nitrosodiethylamine multiple interactions ISO RGD:1550011 6480464 epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in increased expression of GLI1 mRNA] more ... CTD PMID:27058323 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of GLI1 mRNA CTD PMID:21703336 ochratoxin A multiple interactions EXP 6480464 SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of GLI1 mRNA] CTD PMID:21703336 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of GLI1 mRNA CTD PMID:33387578 paraquat multiple interactions ISO RGD:1550011 6480464 tetramethylpyrazine inhibits the reaction [Paraquat results in increased expression of GLI1 mRNA], tetramethylpyrazine inhibits the reaction [Paraquat results in increased expression of GLI1 protein] CTD PMID:30744607 paraquat increases expression ISO RGD:1550011 6480464 Paraquat results in increased expression of GLI1 mRNA, Paraquat results in increased expression of GLI1 protein CTD PMID:30744607 perfluorohexanesulfonic acid decreases expression ISO RGD:1344225 6480464 perfluorohexanesulfonic acid results in decreased expression of GLI1 mRNA CTD PMID:25812627 perfluorononanoic acid decreases expression ISO RGD:1344225 6480464 perfluoro-n-nonanoic acid results in decreased expression of GLI1 mRNA CTD PMID:25812627 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1344225 6480464 perfluorooctane sulfonic acid results in decreased expression of GLI1 mRNA CTD PMID:25812627 perfluorooctanoic acid decreases expression ISO RGD:1344225 6480464 perfluorooctanoic acid results in decreased expression of GLI1 mRNA CTD PMID:25812627 piperonyl butoxide decreases expression ISO RGD:1550011 6480464 Piperonyl Butoxide results in decreased expression of GLI1 mRNA CTD PMID:31642701 piperonyl butoxide multiple interactions ISO RGD:1344225 6480464 Piperonyl Butoxide inhibits the reaction [SHH protein results in increased expression of GLI1 mRNA] CTD PMID:31642701 piperonyl butoxide multiple interactions ISO RGD:1550011 6480464 Piperonyl Butoxide affects the reaction [PTCH1 protein affects the expression of GLI1 protein] more ... CTD PMID:31642701 potassium dichromate multiple interactions ISO RGD:1550011 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of GLI1 mRNA, SHH protein affects the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of GLI1 mRNA] CTD PMID:31756458 progesterone multiple interactions ISO RGD:1550011 6480464 [Estradiol co-treated with Progesterone] results in increased expression of GLI1 mRNA CTD PMID:22958837 quercetin decreases expression ISO RGD:1550011 6480464 Quercetin results in decreased expression of GLI1 mRNA, Quercetin results in decreased expression of GLI1 protein CTD PMID:20395211 quercetin multiple interactions ISO RGD:1344225 6480464 [SHH protein co-treated with Quercetin] results in increased expression of GLI1 protein CTD PMID:33070227 quercetin 3-O-beta-D-galactopyranoside multiple interactions EXP 6480464 hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of GLI1 mRNA], hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of GLI1 protein] CTD PMID:31326407 quercetin 3-O-beta-D-galactopyranoside increases expression EXP 6480464 hyperoside results in increased expression of GLI1 mRNA, hyperoside results in increased expression of GLI1 protein CTD PMID:31326407 quinacrine decreases expression ISO RGD:1344225 6480464 Quinacrine results in decreased expression of GLI1 protein CTD PMID:28720477 quinacrine multiple interactions ISO RGD:1344225 6480464 GSK3B protein affects the reaction [Quinacrine results in decreased expression of GLI1 protein] CTD PMID:28720477 resveratrol decreases activity ISO RGD:1344225 6480464 resveratrol results in decreased activity of GLI1 protein CTD PMID:22397755 resveratrol multiple interactions EXP 6480464 cyclopamine inhibits the reaction [resveratrol results in increased expression of GLI1 protein], resveratrol results in increased expression of and affects the localization of GLI1 protein CTD PMID:24464877 resveratrol multiple interactions ISO RGD:1344225 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of GLI1 mRNA, Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of GLI1 protein] CTD PMID:23557933 , PMID:25069516 resveratrol decreases expression ISO RGD:1550011 6480464 resveratrol results in decreased expression of GLI1 mRNA, resveratrol results in decreased expression of GLI1 protein CTD PMID:20395211 resveratrol decreases expression ISO RGD:1344225 6480464 resveratrol results in decreased expression of GLI1 CTD PMID:22301921 Salinomycin decreases expression ISO RGD:1344225 6480464 salinomycin results in decreased expression of GLI1 mRNA, salinomycin results in decreased expression of GLI1 protein CTD PMID:25499043 , PMID:30273566 silicon dioxide decreases expression ISO RGD:1344225 6480464 Silicon Dioxide analog results in decreased expression of GLI1 mRNA CTD PMID:25895662 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of GLI1 protein CTD PMID:31181250 silicon dioxide multiple interactions EXP 6480464 [goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in increased expression of GLI1 protein] more ... CTD PMID:31181250 silicon dioxide increases expression ISO RGD:1344225 6480464 Silicon Dioxide analog results in increased expression of GLI1 mRNA CTD PMID:23806026 sodium arsenate multiple interactions ISO RGD:1550011 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GLI1 mRNA CTD PMID:34876320 sodium arsenite multiple interactions ISO RGD:1344225 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of GLI1 mRNA CTD PMID:12634122 sodium arsenite multiple interactions ISO RGD:1550011 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GLI1 mRNA CTD PMID:34876320 sodium arsenite decreases expression ISO RGD:1344225 6480464 sodium arsenite results in decreased expression of GLI1 mRNA CTD PMID:34032870 sodium arsenite increases expression ISO RGD:1550011 6480464 sodium arsenite results in increased expression of GLI1 mRNA, sodium arsenite results in increased expression of GLI1 protein CTD PMID:20179202 sodium fluoride multiple interactions EXP 6480464 cyclopamine inhibits the reaction [Sodium Fluoride results in increased expression of GLI1 mRNA], cyclopamine inhibits the reaction [Sodium Fluoride results in increased expression of GLI1 protein] CTD PMID:24388991 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of GLI1 mRNA, Sodium Fluoride results in increased expression of GLI1 protein CTD PMID:24388991 sonidegib decreases expression ISO RGD:1550011 6480464 sonidegib results in decreased expression of GLI1 mRNA CTD PMID:24973920 tamoxifen affects expression ISO RGD:1550011 6480464 Tamoxifen affects the expression of GLI1 mRNA CTD PMID:17555576 tetrachloromethane increases expression ISO RGD:1550011 6480464 Carbon Tetrachloride results in increased expression of GLI1 mRNA, Carbon Tetrachloride results in increased expression of GLI1 protein CTD PMID:31816328 tetrachloromethane multiple interactions ISO RGD:1550011 6480464 GANT 61 inhibits the reaction [Carbon Tetrachloride results in increased expression of GLI1 mRNA], GANT 61 inhibits the reaction [Carbon Tetrachloride results in increased expression of GLI1 protein] CTD PMID:31816328 tetramethylpyrazine multiple interactions ISO RGD:1550011 6480464 tetramethylpyrazine inhibits the reaction [Paraquat results in increased expression of GLI1 mRNA], tetramethylpyrazine inhibits the reaction [Paraquat results in increased expression of GLI1 protein] CTD PMID:30744607 theaflavin multiple interactions ISO RGD:1550011 6480464 theaflavin inhibits the reaction [Diethylnitrosamine results in increased expression of GLI1 mRNA], theaflavin inhibits the reaction [Diethylnitrosamine results in increased expression of GLI1 protein] CTD PMID:27058323 tofacitinib increases expression ISO RGD:1344225 6480464 tofacitinib results in increased expression of GLI1 mRNA CTD PMID:25487280 tolnaftate multiple interactions ISO RGD:1344225 6480464 Tolnaftate inhibits the reaction [SHH protein results in increased expression of GLI1 mRNA] CTD PMID:20434536 tolnaftate multiple interactions ISO RGD:1550011 6480464 Tolnaftate inhibits the reaction [SHH protein results in increased expression of GLI1 mRNA] CTD PMID:20434536 trans-piceid multiple interactions ISO RGD:1550011 6480464 cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA]] more ... CTD PMID:27481074 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of GLI1 mRNA CTD PMID:33387578 triptonide decreases expression ISO RGD:1344225 6480464 triptonide results in decreased expression of GLI1 mRNA, triptonide results in decreased expression of GLI1 protein CTD PMID:30610878 triptonide increases expression ISO RGD:1550011 6480464 triptonide results in increased expression of GLI1 mRNA CTD PMID:33045310 valproic acid increases expression ISO RGD:1344225 6480464 Valproic Acid results in increased expression of GLI1 mRNA CTD PMID:19101580 vincristine increases response to substance ISO RGD:1344225 6480464 GLI1 gene SNP results in increased susceptibility to Vincristine CTD PMID:20864405 vismodegib decreases expression ISO RGD:1344225 150573695 vismodegib decreases Gli1 protein expression in pituitary adenoma cells RGD vismodegib multiple interactions ISO RGD:1344225 6480464 [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in decreased expression of BCL2 protein] more ... CTD PMID:22087285 more ... vismodegib decreases expression ISO RGD:1550011 6480464 HhAntag691 results in decreased expression of GLI1 mRNA CTD PMID:24973920 , PMID:27585885 vismodegib decreases expression ISO RGD:1344225 6480464 HhAntag691 results in decreased expression of GLI1 mRNA CTD PMID:22087285 zinc oxide increases expression ISO RGD:1550011 6480464 Zinc Oxide results in increased expression of GLI1 mRNA CTD PMID:33236829